August 24, 2023

FDA Commissioner Robert Califf said he hopes to see several priorities unfold in the coming years, including reorganizing the Office of Regulatory Affairs (ORA), more effectively harnessing real-world evidence (RWE) and taking an active role in combating misinformation.

During a wide-ranging virtual chat with the Alliance for a Stronger FDA on 22 August, Califf touched on several topics that are important to him. He also discussed the agency’s plans for its proposed unified human foods program (HFP) ahead of its hiring of James Jones to lead the effort.

Read full article on below link.

Oops! Something went wrong while submitting the form.

Recent News

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Read more

Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace

Scientific innovation in Cell & Gene Therapy (C&GT) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions

Read more

Recent blogs

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Read more

Catalyst to Moderate DIA 2025 Panel on Enhancing Innovation in CGT Clinical Trials for Rare Disease

Join us for this dynamic conversation on Monday, June 16th, from 2:15–3:15 PM at DIA. We’d love to connect if you’ll be attending!

Read more

Catalyst to attend FDLI 2025 Annual Conference

If you are attending the FDLI conference, we would love to chat - reach out to us on LinkedIn!

Read more